Vitamin D and Asthma Exacerbations in Children — What Does the Meta-Analysis Show?

Asthma is the most common chronic disease of childhood — presenting as recurrent wheezing, shortness of breath, chest tightness, and coughing, resulting from chronic inflammation and hyperreactivity of the airways. In most children, the disease is well controlled with medication, but exacerbations occur periodically — episodes of marked symptom worsening that require additional treatment, a doctor's visit, and in more severe cases, hospitalization.

Exacerbations aren't just a statistic in clinical trials — for a family they mean sleepless nights, sudden emergency room visits, courses of oral steroids, and missed days of school or a parent's work. The more frequent and severe the exacerbations, the greater the risk of more lasting impairment of lung function into adulthood, which is why the search for safe, additional ways to reduce them — alongside, not instead of, standard treatment — is a subject of ongoing researcher interest.

Vitamin D, known primarily for its role in calcium-phosphate metabolism and bone health — which we cover in more detail in our article on vitamin D3 — has for years also been studied for its effects on the immune system and the airways. This is exactly the thread this article addresses.

The vitamin D receptor (VDR) is present not only in bones, but also in airway epithelial cells and immune system cells, including T lymphocytes and macrophages. Based on this, a hypothesis was formed that vitamin D may modulate the course of asthma on several levels at once: limiting excessive inflammatory response in the airways, supporting the lung's epithelial barrier, and reducing susceptibility to upper respiratory viral infections, which are one of the most common direct causes of asthma exacerbations in children.

An additional argument for this hypothesis came from earlier epidemiological observations linking low vitamin D levels in children with asthma to more frequent exacerbations and worse disease control. Observations of this kind alone don't prove a causal relationship — only trials with random assignment to a supplementation or placebo group can determine whether raising vitamin D levels actually changes the disease course, or whether low vitamin D is merely a marker of other factors.

In other words: in children with asthma who received vitamin D, the risk of an exacerbation during the follow-up period was about 38% lower compared to the placebo group (RR 0.62), and with standard daily dose supplementation the difference was even larger. RR (risk ratio) below 1 means a lower risk of the event in the study group — in this case, a lower risk of asthma exacerbation in the group taking vitamin D than in the placebo group.

An interesting element of the meta-analysis is the difference between standard daily dosing and dosing in the form of less frequent, large bolus doses — the second strategy is sometimes used in clinical practice, since it's easier to remember than daily intake. In this meta-analysis, it was regular, daily dosing that was associated with a stronger protective effect against exacerbations, which may suggest that maintaining a stable, non-fluctuating vitamin D blood level matters more than periodic, sharp increases in it.

This is an observation from a single meta-analysis, not a definitively settled matter — vitamin D dosing in children, including children with asthma, should in every case be determined individually by a doctor, based on the child's age, body weight, and baseline blood 25(OH)D level, not on a single study.

Another common oversimplification is the belief that since vitamin D is available over the counter, it can be dosed to a child arbitrarily, without first checking blood levels. In practice, both deficiency and excess of vitamin D can be problematic, and the response to supplementation may differ depending on whether the child started with a deficiency or a normal level — so it's worth starting with a conversation with a doctor, not with buying a product on your own.

A meta-analysis of ten randomized trials in over a thousand children is a more solid starting point than a single observational study, and the result — a reduction in asthma exacerbations of several tens of percent in the vitamin D-supplemented group — is statistically significant and directionally consistent with the earlier hypothesis about vitamin D's role in the respiratory and immune systems. At the same time, the variety of dosing and baseline vitamin D levels across the component trials calls for caution about exactly how much a specific child will benefit.